In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: Quest Diagnostics shows a 26.9% implied upside with a high-confidence fair value of $250.97 versus a current price of $197.76, indicating potential undervaluation despite fair financial health and weak growth. Monte Carlo analysis reveals high volatility (103.93% CV) and 41.7% downside risk, reflecting significant uncertainty around future returns. Valuation methods vary widely, signaling divergent market and fundamental outlooks.